NKTR - Nektar Therapeutics

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue307,711165,436230,784
Cost of Revenue30,54730,21534,102
Gross Profit277,164135,221196,682
Operating Expenses
Research Development268,461203,801182,787
Selling General and Administrative52,36444,27543,266
Non Recurring15,98115,98115,981
Others---
Total Operating Expenses---
Operating Income or Loss-59,642-112,855-29,371
Income from Continuing Operations
Total Other Income/Expenses Net4,5202,387-12,399
Earnings Before Interest and Taxes-55,122-110,468-41,770
Interest Expense40,95442,18038,901
Income Before Tax-96,076-152,648-80,671
Income Tax Expense616876506
Minority Interest---
Net Income From Continuing Ops-96,692-153,524-95,256
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-96,692-153,524-81,177
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-96,692-153,524-81,177